/ CompletedNot ApplicableIIT Testosterone plus exercise to improve muscle strength and performance in men affected by inclusion body myositis (IBM).
An open-label, phase 2, single centre, randomised, crossover pharmacokinetic study assessing two application areas of 0.5ml (5mg) testosterone 1% cream, ANDROFEME(Registered trademark) in healthy postmenopausal women
/ CompletedNot ApplicableIIT Collaborative Study: Testosterone Antidepressant Augmentation in Women
The investigators' hypotheses are: Low-dose testosterone augmentation improves depressive symptoms in women with Major Depressive Disorder (MDD) and antidepressant partial/nonresponse, adjunctive low-dose testosterone is safe and well-tolerated in women with MDD and antidepressant partial/nonresponse, and low-dose testosterone augmentation improves fatigue and sexual dysfunction.
100 Clinical Results associated with Lawley Pharmaceuticals Pty Ltd.
0 Patents (Medical) associated with Lawley Pharmaceuticals Pty Ltd.
100 Deals associated with Lawley Pharmaceuticals Pty Ltd.
100 Translational Medicine associated with Lawley Pharmaceuticals Pty Ltd.